UBS Group »

Lixte Biotechnology Holdings shares owned by UBS Group

Quarter-by-quarter ownership of Lixte Biotechnology Holdings (LIXT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Lixte Biotechnology Holdings

Tip: Access up to 7 years of quarterly data

All positions including Lixte Biotechnology Holdings held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lixte Biotechnology Holdings by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $6 3 2.33
2023-06-30 $594 101 5.88

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Lixte Biotechnology Holdings

HighTower Advisors
FNY Investment Advisers
Wells Fargo & Company
UBS Group

View all funds holding Lixte Biotechnology Holdings